474 related articles for article (PubMed ID: 32588327)
1. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
Dajon M; Iribarren K; Cremer I
Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
4. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.
Tran TH; Tran TTP; Truong DH; Nguyen HT; Pham TT; Yong CS; Kim JO
Acta Biomater; 2019 Aug; 94():82-96. PubMed ID: 31129358
[TBL] [Abstract][Full Text] [Related]
6. Important aspects of Toll-like receptors, ligands and their signaling pathways.
Chang ZL
Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
[TBL] [Abstract][Full Text] [Related]
7. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
8. Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.
Zapletal E; Vasiljevic T; Busson P; Matijevic Glavan T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982351
[TBL] [Abstract][Full Text] [Related]
9. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
[TBL] [Abstract][Full Text] [Related]
10. The Yin and Yang of Toll-like receptors in cancer.
Pradere JP; Dapito DH; Schwabe RF
Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
[TBL] [Abstract][Full Text] [Related]
11. DAMP-TLR-cytokine axis dictates the fate of tumor.
Patidar A; Selvaraj S; Sarode A; Chauhan P; Chattopadhyay D; Saha B
Cytokine; 2018 Apr; 104():114-123. PubMed ID: 29032985
[TBL] [Abstract][Full Text] [Related]
12. The role of toll-like receptors (TLRs) in pan-cancer.
Huang R; Sun Z; Xian S; Song D; Chang Z; Yan P; Zhang J; Yin H; Zheng Z; Hu P; Li Z; Huang D; Liu Y; Jiang C; Li M; Li S; Meng T; Yang D; Huang Z
Ann Med; 2022 Dec; 54(1):1918-1937. PubMed ID: 35801728
[TBL] [Abstract][Full Text] [Related]
13. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
14. The role of toll-like receptors (TLRs) and their therapeutic applications in endometrial cancer.
Arabian S; Boostan A; Darzi S
Clin Transl Oncol; 2023 Apr; 25(4):859-865. PubMed ID: 36374404
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes.
Paracatu LC; Schuettpelz LG
Front Immunol; 2020; 11():1236. PubMed ID: 32625214
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors: cost or benefit for cancer?
Matijevic T; Pavelic J
Curr Pharm Des; 2010; 16(9):1081-90. PubMed ID: 20030618
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor signaling in parasitic infections.
Ashour DS
Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
[TBL] [Abstract][Full Text] [Related]
18. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
19. The Role of Toll-Like Receptor in Inflammation and Tumor Immunity.
Cen X; Liu S; Cheng K
Front Pharmacol; 2018; 9():878. PubMed ID: 30127747
[TBL] [Abstract][Full Text] [Related]
20. Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy.
Hoden B; DeRubeis D; Martinez-Moczygemba M; Ramos KS; Zhang D
Front Immunol; 2022; 13():1033483. PubMed ID: 36389785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]